Investment projects registered through JIB generated 11,136 jobs compared to 8,578 jobs in 2010 while projects registered through the development zones provided 2,058 jobs.
Of the total investments benefiting from the Investment Promotion Law, Arab investments accounted for 43%, with the United Arab Emirates topping the list of investing countries at JD84m.
Iraq ranked next as its investment volume was JD13m, followed by Lebanon whose investments stood at JD7.3m.
As for non-Arab countries, Canada ranked first with JD120m in investments, followed by the Netherlands at JD31m and India at JD6m.
Accounting for the lion’s share of total investments benefiting from the law, Amman received 82% at JD503m worth of investments, distributed among 130 projects. Of these, foreign investments represented 52%, at JD262m.
The different governorates accounted for the remaining 18% of the total investment volume. Among them, Zarqa’s share was 4%, Balqa 2.7%, Karak 2.4%, Maan 2.2%, Jerash 2.2%, Mafraq 1.6% and Irbid 1.3%. Tafileh, Madaba and Ajloun accounted for the remaining portion.
At the sectoral level, industry accounted for the largest investment volume that benefited from the law, at 79% or JD488m.
The hotel sector ranked second at 12%, followed by the agricultural sector at 4%. The remaining 5% were distributed among projects related to hospitals, maritime, land and railway transport, conferences and exhibition centres and recreation and tourism facilities.
JIB’s Chief Executive Officer, His Excellency Mr. Samer Asfour, said that JIB investment plan for this year, which was presented to the government, focuses on drawing value-added projects that can create and provide job opportunities for Jordanians.
Mr. Asfour added that JIB is currently updating Jordan’s investment map, taking into account the competitive advantages of each governorate to guarantee a just distribution of the economic development gains.
Wednesday, July 13- 2011 @ 14:14 UAE local time (GMT+4) Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of Mediaquest FZ LLC.